MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹20,801 Cr | ₹20,663 Cr | ₹5,315 Cr | ₹5,358 Cr | ₹4,702 Cr |
What is the latest Total Non-Current Assets ratio of MANKIND PHARMA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹20,801 Cr |
| Mar2025 | ₹20,663 Cr |
| Mar2024 | ₹5,315 Cr |
| Mar2023 | ₹5,358 Cr |
| Mar2022 | ₹4,702 Cr |
How is Total Non-Current Assets of MANKIND PHARMA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹20,801 Cr | 0.66 | |
| Mar2025 | ₹20,663 Cr | 288.80 | |
| Mar2024 | ₹5,315 Cr | -0.81 | |
| Mar2023 | ₹5,358 Cr | 13.96 | |
| Mar2022 | ₹4,702 Cr | - | |
Compare Total Non-Current Assets of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹104,276.3 Cr | -0.6% | 6.5% | 7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.6% |
6.5% |
7.1% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses